InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,059.65
(
0.82%
)
US TECH 100
17,066.40
(
1.22%
)
Dow Jones
38,183.25
(
0.74%
)
Brent Oil
83.58
(
0.04%
)
Bitcoin
59,254.11
(
1.75%
)
Post# of 251687
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 82187

Tuesday, 10/27/2009 12:57:15 PM

Tuesday, October 27, 2009 12:57:15 PM

Post# of 251687
GSK/Genmab announced the accelerated approval of Arzerra (ofatumumab) from the FDA for use in patients with chronic lymphocytic leukemia (CLL) that is refractory to fludarabine and alemtuzumab.

http://www.reuters.com/article/marketsNews/idCNLR34044920091027?rpc=44
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up